Development and Challenges of Nasal Spray Vaccines for Short-term COVID-19 Protection

Curr Pharm Biotechnol. 2022;23(14):1671-1677. doi: 10.2174/1389201023666220307092527.
No abstract available

MeSH terms

  • Administration, Intranasal
  • COVID-19* / prevention & control
  • Humans
  • Nasal Sprays
  • Vaccines*

Substances

  • Nasal Sprays
  • Vaccines